Kenvue says post-hoc analysis links earlier 5% minoxidil use to higher hair regrowth in men
KVUE•Kenvue said a post-hoc Phase III analysis linked earlier use of 5% minoxidil foam with stronger hair regrowth outcomes in men with androgenetic alopecia. The findings are slated for presentation at the EADV Congress in Vienna from Sept. 30 to Oct. 3, 2026.
1. Findings for presentation
Kenvue outlined clinical and preclinical findings slated for presentation at the EADV Congress in Vienna from Sept. 30 to Oct. 3, 2026. Its Regaine analysis linked earlier use of 5% minoxidil foam with stronger hair regrowth outcomes in men with androgenetic alopecia; separate Neutrogena studies indicated niacinamide-based sunscreens improved visible acne-related marks and hydration, while Aveeno data suggested colloidal oat formulations helped reinforce skin-barrier recovery.
